AAAAAA
Results:
1-12
|
Results: 12
Authors:
CUTLER CS
MICHEL RP
YASSA M
LANGLEBEN A
Citation: Cs. Cutler et al., PULMONARY BLASTOMA - CASE-REPORT OF A PATIENT WITH A 7-YEAR REMISSIONAND REVIEW OF CHEMOTHERAPY EXPERIENCE IN THE WORLD LITERATURE, Cancer, 82(3), 1998, pp. 462-467
Authors:
LACHAINE J
LAURIER C
LANGLEBEN A
VAILLANT L
Citation: J. Lachaine et al., COST-EFFECTIVENESS AND QUALITY-OF-LIFE EVALUATION, IN THE CONTEXT OF CURRENT PRACTICE, OF ANTIEMETICS USED FOR THE CONTROL OF CHEMOTHERAPY-INDUCED EMESIS, European journal of cancer, 33, 1997, pp. 16-16
Authors:
ROBERTS JA
JENISON EL
KIM KM
CLARKEPEARSON D
LANGLEBEN A
Citation: Ja. Roberts et al., A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY OF ORG-2766 IN THE PREVENTION OR DELAY OF CISPLATIN-INDUCEDNEUROPATHIES IN WOMEN WITH OVARIAN-CANCER, Gynecologic oncology, 67(2), 1997, pp. 172-177
Authors:
CRAWFORD J
OROURKE M
SCHILLER JH
SPIRIDONITIS CH
YANOVICH S
OZER H
LANGLEBEN A
HUTCHINS L
KOLETSKY A
CLAMON G
BURMAN S
WHITE R
HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
Authors:
PREUL MC
CARAMANOS Z
SHENOUDA G
LANGLEBEN A
VILLEMURE JG
LEBLANC RA
OLIVIER A
TAMPIERI D
BAHARY JP
ARNOLD DL
Citation: Mc. Preul et al., IN-VIVO BIOCHEMICAL EFFECTS OF TAMOXIFEN ON RECURRENT MALIGNANT ASTROCYTOMAS - CHARACTERISTICS OF RESPONSE AND FAILURE, Journal of neurosurgery, 84(2), 1996, pp. 763-763
Authors:
VIALLET J
ROUSSEAU T
SOUHAMI L
AYOUB J
DELVECCHIO P
KREISMAN H
GUERRA J
LANGLEBEN A
KERBY W
HUNT H
Citation: J. Viallet et al., COMPLETED PHASE I II TRIAL OF NEOADJUVANT CHEMOTHERAPY (CT) WITH CISPLATIN AND VINORELBINE FOLLOWED BY ACCELERATED THORACIC IRRADIATION, (TRT) IN INOPERABLE NSCLC/, European journal of cancer, 31A, 1995, pp. 1083-1083
Authors:
MILLER AA
HERNDON JE
HOLLIS DR
ELLERTON J
LANGLEBEN A
RICHARDS F
GREEN MR
Citation: Aa. Miller et al., SCHEDULE DEPENDENCY OF 21-DAY ORAL VERSUS 3-DAY INTRAVENOUS ETOPOSIDEIN COMBINATION WITH INTRAVENOUS CISPLATIN IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY OF THE CANCER AND LEUKEMIA GROUP-B, Journal of clinical oncology, 13(8), 1995, pp. 1871-1879
Authors:
TRUDEAU M
ZUKIWSKI A
LANGLEBEN A
BOOS G
BATIST G
Citation: M. Trudeau et al., A PHASE-I STUDY OF RECOMBINANT HUMAN INTERFERON-ALPHA-2B COMBINED WITH 5-FLUOROURACIL AND CISPLATIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 35(6), 1995, pp. 496-500
Authors:
PREUL MC
VILLEMURE JG
LANGLEBEN A
BAHARY JP
SHENOUDA G
LEBLANC R
POKRUPA R
OLIVIER A
ARNOLD D
Citation: Mc. Preul et al., BIOCHEMICAL EFFECTS OF HIGH-DOSE TAMOXIFEN FOR RECURRENT MALIGNANT GLIOMA MONITORED IN-VIVO WITH H-1-MR SPECTROSCOPIC IMAGING, Journal of neurosurgery, 80(2), 1994, pp. 10000413-10000414
Authors:
BALTUCH G
SHENOUDA G
LANGLEBEN A
VILLEMURE JG
Citation: G. Baltuch et al., HIGH-DOSE TAMOXIFEN IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMA -A REPORT OF CLINICAL STABILIZATION AND TUMOR-REGRESSION, Canadian journal of neurological sciences, 20(2), 1993, pp. 168-170
Authors:
TRUDEAU M
ZUKIWSKI A
LANGLEBEN A
BOOS G
HAYDEN K
BATIST G
Citation: M. Trudeau et al., A PHASE-I STUDY OF ESCALATING INTERFERON ALPHA-2A COMBINED WITH 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH GASTROINTESTINAL MALIGNANCIES, Acta oncologica, 32(5), 1993, pp. 537-539
Authors:
STEWART DJ
EISENHAUER E
MACDONALD DR
CAIRNCROSS JG
LANGLEBEN A
Citation: Dj. Stewart et al., PHASE-II STUDY OF TIAZOFURIN IN GLIOMAS IN ADULTS - A NATIONAL-CANCER-INSTITUTE-OF-CANADA STUDY, Journal of neuro-oncology, 15(2), 1993, pp. 175-179
Risultati:
1-12
|